about
Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart.In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy.Zinc transporters and insulin resistance: therapeutic implications for type 2 diabetes and metabolic disease.Endothelium Independent Effect of Pelargonidin on Vasoconstriction in Rat Aorta.Hypothermia Inhibits Endothelium-Independent Vascular Contractility via Rho-kinase Inhibition.A combined tissue engineered / in silico signature tool for patient stratification in lung cancer.
P2860
Q37707024-D9B490BD-32F9-4888-828D-76F743597E32Q39263982-30269CC2-7024-439C-877B-06A7FC4BB38DQ41471609-EC44C0E5-A122-48B1-B22A-6820E16CAF60Q47127733-7DCE7BB4-E3D8-42DD-AE45-D772FFC226CEQ49488230-DBC9EF58-CC7D-4607-BC66-C1F49E067801Q53121132-FA69010F-3C82-47A3-A577-E9A57EB6B2E4Q54978277-501A34C0-091A-4247-A23B-2FBE5890DC63
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Analyzing ERK 1/2 signalling and targets.
@en
type
label
Analyzing ERK 1/2 signalling and targets.
@en
prefLabel
Analyzing ERK 1/2 signalling and targets.
@en
P2093
P2860
P356
P1433
P1476
Analyzing ERK 1/2 signalling and targets.
@en
P2093
Alexandra Brietz
Gaby Wangorsch
Kristin Verena Schuch
P2860
P304
P356
10.1039/C6MB00255B
P577
2016-06-15T00:00:00Z